ArticleBMC infectious diseases2025
Next-generation sequencing reveals viral aetiologies of encephalitis in Ghana: a prospective cross-sectional study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
In Ghana, cerebrospinal fluid polymerase chain reaction (PCR) is the primary diagnostic tool for viral encephalitis. However, its application remains limited, and diagnosis is predominantly syndromic. Current data on encephalitis in Ghana are sparse and often restricted to sporadic cases, with improved PCR diagnostics elucidating some aetiological agents but leaving approximately 60% of cases undiagnosed. This diagnostic gap arises because PCR targets specific pathogens, overlooking unexpected or novel agents. Consequently, tailored patient management is hindered, patient outcomes are adversely affected, and efforts to understand the true burden of viral encephalitis are impeded. To address these challenges, we conducted a cross-sectional study at the Komfo Anokye Teaching Hospital, a major tertiary referral centre in Ghana, from May 2019 to August 2022. Forty-three (43) cerebrospinal fluid samples from suspected encephalitis patients were analysed using Polymerase chain reaction (PCR) and high-throughput next-generation sequencing (NGS) to identify a broader range of viral pathogens and assess the role of co-infections in disease outcomes. Viral encephalitis was detected in 42% (18/43) of samples, revealing 11 viruses across six families. Herpesviruses (34%) and retroviruses (28%) were the most prevalent, with human immunodeficiency virus-1 (HIV-1) and enteroviruses identified as the primary causative agents. NGS identified a broader viral spectrum, detecting 6 additional viruses (HIV-1, EBV, Mumps, HHV-6, HRV, Rotavirus A) which were not targeted by PCR. While NGS and PCR demonstrated comparable sensitivity for certain pathogens, NGS identified additional co-infections (39%, 7/18) and rare viruses. The survival rate for patients with co-infections was 28.6% (2/7), with HIV-1 and herpesviruses implicated in 85.7% (6/7) of co-infected cases. This study highlights the potential of NGS to expand the diagnostic capabilities for viral encephalitis. By overcoming the limitations of PCR, NGS provides a more comprehensive approach, enhancing our understanding of the true burden of viral encephalitis in Ghana and informing better patient management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.